(Press-News.org) The antimalarial drug mefloquine could help treat genetic diseases such as cystic fibrosis, Duchenne muscular dystrophy, as well as some cancers.
In these diseases, a mutation in the genetic code introduces a stop signal in completely the wrong place, leading to the production of a shortened protein. An international team of researchers, including scientists of the University of Groningen, have now demonstrated how the antimalarial drug mefloquine can enhance the effect of aminoglycosides, another class of drugs, to override the incorrect stop signal.
Side effects
Aminoglycosides can override the stop signal on their own, but this requires a very high dose, causing many side effects. As mefloquine boosts the efficiency of aminoglycosides, the combination allows for a lower, less harmful dose of aminoglycosides. Although the positive effects of mefloquine on aminoglycosides were already known, the current study revealed the way mefloquine binds to the ribosomes, the cell organelle where proteins are produced. The exact binding site on the ribosomes was previously unknown, and the study revealed a novel mechanism through which future drugs could potentially override the erroneous stop signal.
Something completely unexpected
The next step is to study the newly discovered mechanism in cells and animal models. Eventually, the mechanism could spark the development of new drugs tackling the faulty stop signals. Lead author Albert Guskov, associate professor and Head of the University of Groningen Biomolecular X-ray Crystallography Lab: ‘It was exciting to discover something completely unexpected, a new mechanism that explains how drugs can help override a faulty stop signal. A very thrilling and motivating discovery.’
Reference: Olga Kolosova et al. Mechanism of read-through enhancement by aminoglycosides and mefloquine. Proceedings of the National Academy of Sciences, 25 April 2025
END
How an antimalarial drug could help fix genetic diseases
2025-04-23
ELSE PRESS RELEASES FROM THIS DATE:
Severe, lasting impairment that some consider ‘worse than death’ affects many residents after long-term care admission
2025-04-23
Ottawa, ON, April 23, 2025 – 20% of residents newly admitted to long-term care became permanently unable to make everyday decisions for themselves within five years, according to new research from Bruyère Health Research Institute and ICES.
A significant number of long-term care (LTC) residents experience states of severe cognitive and physical impairment, leaving them unable to make personal decisions—like what to eat or what to wear—and unable to communicate with staff or loved ones.
“Our study set out to trace the experiences of residents newly admitted to long-term care, and ...
Cognitive and functional decline among long-term care residents
2025-04-23
About The Study: In this study, severe permanent impairment in function and cognition were common and often present near the end of life for long-term care residents, but a minority of residents lived in these states for years. These results suggest that building shared understanding and open communication about the natural course of frailty trajectories for long-term care residents may support resident-centered medical decision-making.
Corresponding Author: To contact the corresponding author, Daniel Kobewka, MD, MSc, email dkobewka@toh.ca.
To access the embargoed study: Visit our For The Media website at this link ...
Screening and response for adverse social determinants of health in US emergency departments
2025-04-23
About The Study: Despite the high prevalence of adverse social determinants of health (SDOH) in emergency department (ED) populations, in this survey study of 232 EDs, less than one-third performed screening, and one-fifth did not have policies requiring a response to positive screens. Bridging this gap may require expanding adverse SDOH screening practices while also ensuring that EDs have the resources and infrastructure to respond appropriately to identified social needs. Future research might explore advanced technological solutions ...
How DNA self-organizes in the early embryo
2025-04-23
Early DNA Organization is Robust and Flexible
When the egg and sperm fuse, a comprehensive reorganization of DNA begins within the nucleus. Epigenetics plays a crucial role in this process, regulating gene activity through chemical modifications on DNA and its associated proteins. “We wanted to understand how these epigenetic programs influence gene activity and ensure that the cell correctly executes its developmental tasks,” explains study leader Prof. Maria-Elena Torres-Padilla, Director at the Institute of Epigenetics ...
Remembering the cold: scientists discover how memories control metabolism
2025-04-23
New multidisciplinary research led by Prof. Tomás Ryan from Trinity College Dublin shows that the brain forms memories of cold experiences and uses them to control our metabolism. This newly published study is the first to show that cold memories form in the brain – and map out how they subsequently drive thermoregulation.
The discovery may have important applications in therapies designed to treat a range of disorders – from obesity to cancer – in which thermoregulation and metabolism (or a lack of control in this area) plays a role, as ...
Phoenician culture spread mainly through cultural exchange
2025-04-23
To the point
Secret of the Phoenician-Punic civilization's success: Their culture spread across the Mediterranean not through large-scale mass migration, but through a dynamic process of cultural transmission and assimilation.
Melting pot of ancient people: The study found that Punic populations had a highly variable and heterogeneous genetic profile, with significant North African and Sicilian-Aegean ancestry.
Highly interconnected: Ancient Mediterranean societies were cosmopolitan, with people from different regions trading, moving often over large distances and having offspring with each other. This provides new insights into the region's cultural and population history in ...
Smoking cessation drug varenicline helps young adults quit vaping
2025-04-23
A new study by investigators from Mass General Brigham showed that teens and young adults who took varenicline—an FDA-approved, twice-daily smoking cessation pill for adults—are more than three times as likely to successfully quit vaping compared to those who received only behavioral counseling. Results are published in JAMA.
“Vaping is extremely popular among kids, and we know that this early nicotine exposure can make drugs like cocaine more addictive down the line, yet ours is the first ...
How bacteria in our aging guts can elevate risk of leukemia and perhaps more
2025-04-23
CINCINNATI—Scientists at Cincinnati Children’s along with an international team of researchers have discovered a surprising new connection between gut health and blood cancer risk—one that could transform how we think about aging, inflammation, and the early stages of leukemia.
As we grow older—or in some cases, when gut health is compromised by disease—changes in the intestinal lining allow certain bacteria to leak their byproducts into the bloodstream. One such molecule, produced by specific bacteria, acts as a signal that accelerates the expansion of dormant, pre-leukemic blood cells, a critical step ...
Four generations help science explore genome mutation rate
2025-04-23
An advanced genomic analysis of a multigenerational family is providing new knowledge about genetic mutations and their transmission, both the variants that are inherited and those that arise anew.
The findings are published today, April 23, in Nature.
“We sequenced and assembled the chromosomes of multiple members of a large, four-generation family to understand how the genetic information changed from generation to generation,” said Evan E Eichler, professor of genome sciences at the University of Washington School of Medicine in Seattle and the corresponding author of the paper.
During the study, lead author David Porubsky was a postdoctoral fellow at the UW. Porubsky ...
Mathematician and biochemist win transdisciplinary research prize
2025-04-23
The Transdisciplinary Research Areas (TRAs) Modelling and Life and Health at the University of Bonn have presented their €100,000 research prize, entitled “Modelling for Life and Health,” for the second time. The winners—Argelander Professor Ana Ivonne Vazquez-Armendariz and Schlegel Professor Jan Hasenauer—will be using their prize money to study the functions of “scavenger cells” in the lungs at the interface between mathematics and medicine.
The lung’s very own scavenger cells, known as alveolar macrophages, ...